HIV-1 DNA vaccines and chemokines.
DNA vaccines have a demonstrated ability to induce humoral and cellular immune responses in animal models and humans. The technology, although it dates back to the 1950's, has had an insurgence of interest within the past few years following concurrent research papers. The basic technology is being applied broadly to viral, bacterial and parasitic infections. It has also been demonstrated that genes delivered via plasmid expression vectors result in expression of functional proteins in the inoculated host. Further, injection of plasmids encoding cytokine, chemokine or co-stimulatory molecules, also referred to as immunomodulatory plasmids can lead to the further expansion of this technology to include directed immunology. We have been developing DNA technology specifically with a focus as a vaccine against HIV-1 infection. We report that such vaccines can stimulate immune responses in a variety of relevant animal systems including humoral and cellular responses as well as the production of beta-chemokines. We describe that the beta-chemokines can both modulate the immune response induced by DNA vaccines and be modulated by the DNA vaccines in the murine and chimpanzee models as well as in humans.
Boyer
J D
JD
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Kim
J
J
Ugen
K
K
Cohen
A D
AD
Ahn
L
L
Schumann
K
K
Lacy
K
K
Bagarazzi
M L
ML
Javadian
A
A
Ciccarelli
R B
RB
Ginsberg
R S
RS
MacGregor
R R
RR
Weiner
D B
DB
D016915:AIDS Vaccines; D000818:Animals; D018925:Chemokines / Q000276:immunology*; D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000276:immunology*; D005260:Female; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D002679:Pan troglodytes; D014407:Tumor Cells, Cultured
D016915:AIDS Vaccines; D018925:Chemokines; D004279:DNA, Viral